Trial intelligence / Profile preview

ATGL and G0/G1 Switch Gene in LPS-Induced Ketosis

NCT02157155Completed

Sponsor
Aarhus University
Start
Jun 2014
Primary completion
Mar 2015
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Aarhus University. Primary endpoint: Insulin signaling expressed as a CHANGE in phosphorylation of intracellular target proteins and CHANGE in mRNA expression of target genes in muscle- and fat-tissue. Started Jun 2014; status: completed.

Beyond the preview

Go deeper on NCT02157155.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02157155.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call